#USA #Sarasota #Spectrum Dynamics #Veritas.AI #VERITON-CT

Spectrum Dynamics Medical's Veritas.AI™: A New Era in Imaging Technology

On January 29, 2026, Spectrum Dynamics Medical, an industry trailblazer in digital nuclear medicine imaging, proudly announced the receipt of FDA 510(k) clearance for its groundbreaking platform, Veritas.AI™. This innovative artificial intelligence technology is engineered to significantly enhance both image quality and operational efficiency on the VERITON-CT® system—a digital SPECT/CT system that represents the future of molecular imaging.

The Innovation of Veritas.AI™

Veritas.AI™ represents a considerable advancement in the field of molecular imaging. With the ability to employ a deep learning convolutional neural network (CNN), this AI-powered platform intelligently reduces image noise while ensuring the preservation of high spatial resolution and quantitative accuracy. Clinically validated for diverse applications, including bone imaging, Lu-177 theranostics, and I-123 MIBG, Veritas.AI™ is tailored to meet the challenges of demanding imaging scenarios in nuclear medicine.

One of the standout features of Veritas.AI™ is its ability to compress scanning times by up to 50%, a significant benefit for both clinicians and patients. It enhances image quality even in low-count and high-noise conditions, thus enabling healthcare providers to maintain diagnostic accuracy, optimize patient comfort, and improve department throughput. In contrast to traditional denoising approaches, Veritas.AI™ operates seamlessly across a multitude of imaging conditions, ranging from standard diagnostic scans to post-therapy evaluations.

Tailored Applications for Enhanced Performance

The Veritas.AI Noise Reduction suite is segmented into specific applications designed to address unique clinical needs:

• - Bone-IQ.AI: This application allows for a reduction in scan times by up to 50% for whole-body bone imaging, thus enhancing throughput capabilities to accommodate 2-3 patients per hour without compromising on image quality.

• - Thera-IQ.AI: Specifically developed for Lu-177 theranostics, this application enhances post-treatment image quantitative accuracy, streamlining noise across different time points which can bolster dosimetry accuracy and improve lesion detectability.

• - MIBG-IQ.AI: This application focuses on I-123 MIBG imaging, allowing for a remarkable reduction in scan time by up to 50%, thereby ensuring faster, safer, and more comfortable examinations for pediatric patients.

These tailored applications work in conjunction with the VERITON-CT's cutting-edge 360° CZT digital detector architecture, a wide-bore design, and workflows ready for quantitation, thus reinforcing Spectrum Dynamics Medical's supremacy in the domain of digital SPECT/CT imaging. This advanced technology not only supports routine clinical practices but is also a game-changer for theranostics and clinical research.

A Significant Milestone for Healthcare

Tomer Gabay, Chief Executive Officer of Spectrum Dynamics Medical, expressed his enthusiasm regarding this FDA clearance, describing it as a pivotal moment for both the company and the nuclear medicine community. He emphasized that as leaders in innovation, the introduction of Veritas.AI™ aligns with their commitment to precision imaging—providing clearer images, increasing confidence during diagnostics, and creating efficient workflows in healthcare settings. Moreover, this advancement aids hospitals in preparing for the rapid ascent of theranostics and quantitative SPECT/CT practices.

The FDA's approval is not just a regulatory achievement; it marks a substantial leap forward in Spectrum Dynamics' ongoing investment in AI-driven solutions, setting an elevated benchmark for clarity, confidence, and clinical efficacy within nuclear medicine.

About Spectrum Dynamics Medical

Spectrum Dynamics Medical is pioneer in the transformation of SPECT imaging systems, shifting from traditional analog methods to modern digital detection technologies. This evolution provides hospitals and healthcare professionals with improved image quality, operational efficiency, and access to advanced clinical applications. Spectrum Dynamics made headlines in 2007 with the launch of the world’s first digital cardiac SPECT system, D-SPECT CARDIO, which has since dominated the functional cardiac imaging market worldwide. More recently, with the introduction of the VERITON® and VERITON-CT® SPECT/CT systems, the company continues to lead the way in nuclear medicine imaging advancements. To learn more about their groundbreaking technologies, visit Spectrum Dynamics.